129 related articles for article (PubMed ID: 32674992)
1. Acute effects of a session of electroconvulsive therapy on brain-derived neurotrophic factor plasma levels.
Bioque M; Mac-Dowell KS; Font C; Meseguer A; Macau E; Garcia-Orellana M; Valentí M; Leza JC; Bernardo M
Span J Psychiatry Ment Health; 2023; 16(3):137-142. PubMed ID: 32674992
[TBL] [Abstract][Full Text] [Related]
2. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
3. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
[TBL] [Abstract][Full Text] [Related]
4. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning - a preliminary observations.
Ciszowski K; Gomółka E; Gawlikowski T; Szpak D; Potoczek A; Boba M
Przegl Lek; 2016; 73(8):552-9. PubMed ID: 29677430
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy.
Pacitti F; Bersani G; Aloe L; Caredda M; Orsi P; Quartini A; Vitali M; Ceccanti M; Tirassa P; Fiore M; Iannitelli A
Clin Ter; 2021; 171(1):e67-e74. PubMed ID: 33346332
[TBL] [Abstract][Full Text] [Related]
7. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
8. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats.
Sartorius A; Hellweg R; Litzke J; Vogt M; Dormann C; Vollmayr B; Danker-Hopfe H; Gass P
Pharmacopsychiatry; 2009 Nov; 42(6):270-6. PubMed ID: 19924587
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
10. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
Kranaster L; Hellweg R; Sartorius A
Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
[TBL] [Abstract][Full Text] [Related]
11. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis.
Wang Z; Zou Z; Xiao J; Min W; Nan LP; Yuan C; Yuan L; Yang C; Huang R; He Y
Gen Hosp Psychiatry; 2023; 83():86-92. PubMed ID: 37148598
[TBL] [Abstract][Full Text] [Related]
13. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
Ryan KM; Dunne R; McLoughlin DM
Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
[TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients.
Lin CH; Chen MC; Lee WK; Chen CC; Huang CH; Lane HY
Neuropsychobiology; 2013; 68(2):110-5. PubMed ID: 23881232
[TBL] [Abstract][Full Text] [Related]
15. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.
Bumb JM; Aksay SS; Janke C; Kranaster L; Geisel O; Gass P; Hellweg R; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):227-32. PubMed ID: 25231834
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
[TBL] [Abstract][Full Text] [Related]
18. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis.
Luan S; Zhou B; Wu Q; Wan H; Li H
Asian J Psychiatr; 2020 Jun; 51():101983. PubMed ID: 32146142
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome.
van Zutphen EM; Rhebergen D; van Exel E; Oudega ML; Bouckaert F; Sienaert P; Vandenbulcke M; Stek M; Dols A
Transl Psychiatry; 2019 May; 9(1):155. PubMed ID: 31127089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
